Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed
about
Tumor-derived exosomes in cancer progression and treatment failureTargeting Immune Regulatory Networks to Counteract Immune Suppression in CancerCancer: fundamentals behind pH targeting and the double-edged approachEffect of Modified Alkaline Supplementation on Syngenic Melanoma Growth in CB57/BL MiceHigh dose lansoprazole combined with metronomic chemotherapy: a phase I/II study in companion animals with spontaneously occurring tumors.Extracellular vesicles as shuttles of tumor biomarkers and anti-tumor drugsTumor metabolism, cancer cell transporters, and microenvironmental resistance.Microenvironmental acidosis in carcinogenesis and metastases: new strategies in prevention and therapy.Intermittent high dose proton pump inhibitor enhances the antitumor effects of chemotherapy in metastatic breast cancerProton pump inhibitors for the treatment of cancer in companion animals.Influence of the proton pump inhibitor lansoprazole on distribution and activity of doxorubicin in solid tumors.Evidence-based support for the use of proton pump inhibitors in cancer therapyAltered pH gradient at the plasma membrane of osteosarcoma cells is a key mechanism of drug resistance.Antitumor effect of combination of the inhibitors of two new oncotargets: proton pumps and reverse transcriptase.Acridine Orange/exosomes increase the delivery and the effectiveness of Acridine Orange in human melanoma cells: A new prototype for theranostics of tumors.Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice.A nonmainstream approach against cancer.Lansoprazole and carbonic anhydrase IX inhibitors sinergize against human melanoma cells.Carbonic anhydrase IX inhibition is an effective strategy for osteosarcoma treatment.Proton pump inhibitors while belonging to the same family of generic drugs show different anti-tumor effect.Association of proton pump inhibitors with the occurrence of gut-derived bacteraemia in patients with haematological malignancy after chemotherapy.Proton pump inhibitors increase the chemosensitivity of patients with advanced colorectal cancer.Tumor microenvironment interruption: a novel anti-cancer mechanism of Proton-pump inhibitor in gastric cancer by suppressing the release of microRNA-carrying exosomes.Restoring microenvironmental redox and pH homeostasis inhibits neoplastic cell growth and migration: therapeutic efficacy of esomeprazole plus sulfasalazine on 3-MCA-induced sarcoma.Repositioning of proton pump inhibitors in cancer therapy.Rethinking the Combination of Proton Exchanger Inhibitors in Cancer Therapy.Cluster of differentiation 147 mediates chemoresistance in breast cancer by affecting vacuolar H+-ATPase expression and activity.pH regulators to target the tumor immune microenvironment in human hepatocellular carcinoma.
P2860
Q26785408-6FB29800-1A35-4CE2-A611-B038618AF516Q28066486-0BA554C6-0269-48DA-9796-7F2DB9306F47Q28821351-DDCEF4AB-D028-4FD6-9784-EF0FACB88C4FQ31116734-8BDBF620-474B-4429-AF44-DCE386D3B9F2Q34091419-38CE5633-78F1-406B-9CC4-738A9EA70BF1Q34304788-AB2A3C7B-84CF-4C3E-A744-C40B44B3E5A3Q34513382-16877DA5-6900-40A1-ACB7-C49F11217AAEQ34573748-43D7F613-C4F1-432D-B190-0D7A9E960E32Q35987082-A727189F-5930-4014-8EFB-6C167EA8AC7FQ36027301-838DB84E-9476-438F-BDD5-554F1802AAD4Q36262935-7462FD79-A990-4822-BE86-5CF293379004Q36310900-5459D3DF-9306-4BBE-A771-B092E9ABE02DQ37665338-A9FCF8F1-5512-40C1-B5CB-FF5A33143643Q37706150-45FEF6B4-B350-4EE1-A4A1-65AB102BE5ACQ38713579-3D23ACFD-13F3-4A9B-B677-A692F2EB5767Q38720922-AB19EEB2-EAC6-4447-8270-C3A1FB55036BQ38772824-55EA1EFE-565F-4D63-833C-3D0BBEB99D1DQ38773386-AEA94C10-CC3D-4C8E-A850-0BEE93FFF31AQ38836322-26E8F010-D064-4DBF-A5F7-27E931256893Q38870220-E1449C24-7079-4CE5-A8D6-6FFAC84676CBQ39851554-B25E2244-2F1F-42CF-AFD9-1BA3A038F878Q41709117-A478E95D-C7C6-47B7-90D8-8DF8EB2826AEQ41769227-77726C90-ED49-496E-9F15-912A616D0C00Q42366554-A841E2E2-9BC3-4F74-981B-6B7B9F89E219Q48142620-7ECB0F31-266E-460C-A1C2-89F16FCCFA02Q48552373-92D0B3B7-F417-4E4A-AD21-6C9FBE158F3AQ55257994-1F45236C-14B3-4F61-B057-7E3EF5EEC563Q55397692-D83A3543-6885-4B66-A77D-03687E684084
P2860
Proton pump inhibitor chemosensitization in human osteosarcoma: from the bench to the patients' bed
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Proton pump inhibitor chemosen ...... the bench to the patients' bed
@en
Proton pump inhibitor chemosen ...... he bench to the patients' bed.
@nl
type
label
Proton pump inhibitor chemosen ...... the bench to the patients' bed
@en
Proton pump inhibitor chemosen ...... he bench to the patients' bed.
@nl
prefLabel
Proton pump inhibitor chemosen ...... the bench to the patients' bed
@en
Proton pump inhibitor chemosen ...... he bench to the patients' bed.
@nl
P2860
P50
P356
P1476
Proton pump inhibitor chemosen ...... the bench to the patients' bed
@en
P2093
Adalberto Brach Del Prever
Stefano Ferrari
P2860
P2888
P356
10.1186/1479-5876-11-268
P50
P577
2013-10-24T00:00:00Z
P5875
P6179
1030037494